Patents Assigned to Merck Patent GmbH
  • Publication number: 20190256499
    Abstract: Substituted quinoxaline derivatives are useful for the prevention and/or treatment of medical conditions known as hyperproliferative diseases. The compounds are also useful for medical conditions that are affected by inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB). Further, the compounds are useful for the prevention and/or treatment of cancer.
    Type: Application
    Filed: November 6, 2017
    Publication date: August 22, 2019
    Applicant: Merck Patent GmbH
    Inventor: Hans-Peter Buchstaller
  • Publication number: 20190256777
    Abstract: The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, to liquid-crystal media comprising them, and to the use of the polymerizable compounds and liquid crystalline media for optical, electro-optical and electronic purposes, in particular in liquid crystalline displays, especially in liquid crystalline displays of the polymer sustained alignment type.
    Type: Application
    Filed: May 1, 2019
    Publication date: August 22, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Qiong TONG, Nico SCHWEBEL, Constanze BROCKE, Kaja DEING, Julian VOGT, Elisabeth MEYER
  • Publication number: 20190256819
    Abstract: The present invention relates to a process for improving the solubility or dissolution behaviour of components in an aqueous solution. The dissolution properties of a slowly/badly dissolving component can be positively affected by generating mixed particles of this component with another component which has a negative dissolution enthalpy. By preparing and adding such mixed particles solubility is improved without changing the chemical composition.
    Type: Application
    Filed: July 25, 2017
    Publication date: August 22, 2019
    Applicant: Merck Patent GmbH
    Inventors: Joerg VON HAGEN, Andrew SALAZAR, Markus LUBDA
  • Patent number: 10386556
    Abstract: The invention relates to a RM lens obtainable from a polymerizable liquid crystalline medium comprising, a polymerizable liquid crystalline component A comprising one or more polymerizable mesogenic compounds, and at most 12% by weight of the total medium of a non-mesogenic component B. Moreover, the invention relates to the use of such birefringent RM lenses in electro optical devices, such as liquid crystal displays (LCDs) or other optical or electrooptical devices, for decorative or security applications.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: August 20, 2019
    Assignee: Merck Patent GmbH
    Inventor: Joseph Sargent
  • Patent number: 10388884
    Abstract: The present application relates to a material comprising a monoarylamine of a formula (A) and a p-dopant of a defined formula. The present application further relates to the use of said material in an organic layer of an electronic device, the device preferably being an organic electroluminescent device (OLED).
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: August 20, 2019
    Assignees: Merck Patent GmbH, OSRAM OLED GmbH
    Inventors: Joachim Kaiser, Christof Pflumm, Arndt Jaeger, Thomas Dobbertin, Guenter Schmid
  • Publication number: 20190248907
    Abstract: The present invention provides antibodies and heterodimeric immunoglobulin molecules, which bind cMET with high affinity and can be used to target cMET expressing tumor cells. The present invention also discloses methods of generating anti-cMET antibody drug conjugates using the inventive antibodies or heterodimeric immunoglobulin molecules as disclosed herein.
    Type: Application
    Filed: September 14, 2017
    Publication date: August 15, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Achim DOERNER, Lars TOLEIKIS, Birgit PIATER, Laura RHIEL, Christine KNUEHL, Carolin SELLMANN, Simon KRAH
  • Publication number: 20190252628
    Abstract: The present invention relates to binuclear metal complexes and electronic devices, in particular organic electroluminescent devices containing said metal complexes.
    Type: Application
    Filed: October 10, 2017
    Publication date: August 15, 2019
    Applicant: Merck Patent GmbH
    Inventors: Philipp Stoessel, Nils Koenen, Christian Ehrenreich
  • Patent number: 10381575
    Abstract: The present invention relates to a compound, comprising a pyrene skeleton and arylamino groups, according to formula (I). The compound is suitable for use as a functional material in electronic devices.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: August 13, 2019
    Assignee: Merck Patent GmbH
    Inventors: Holger Heil, Anja Gerhard, Fabrice Eckes, Amandine Darsy
  • Patent number: 10377766
    Abstract: The invention relates to heterocyclic compounds with benzo[c]coumarin structures and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: August 13, 2019
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Teresa Mujica-Fernaud, Thomas Eberle, Anja Jatsch, Jonas Valentin Kroeber, Tobias Grossmann
  • Patent number: 10377745
    Abstract: The present invention relates to heterocyclic compounds, and pharmaceutically acceptable compositions thereof, useful as Nav1.6 inhibitors.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: August 13, 2019
    Assignee: Merck Patent GmbH
    Inventors: Brian A. Sherer, Nadia Brugger
  • Patent number: 10381576
    Abstract: The present application relates to an organic electroluminescent device (OLED) comprising an emitting layer, where the emitting layer includes a compound having a small difference between the energies of the S1 and T1 states, and further comprising a layer which has been applied from solution between the emitting layer and anode and comprises an amine compound. The present application further relates to a process for producing such an OLED.
    Type: Grant
    Filed: November 16, 2015
    Date of Patent: August 13, 2019
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Amir Hossain Parham, Christof Pflumm, Anja Jatsch, Joachim Kaiser, Herwig Buchholz
  • Publication number: 20190241808
    Abstract: The present invention relates to a liquid crystal (LC) medium comprising polymerisable compounds, to a process for its preparation, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, and to LC displays comprising it.
    Type: Application
    Filed: October 16, 2017
    Publication date: August 8, 2019
    Applicant: Merck Patent GmbH
    Inventors: Nils GREINERT, Matthias BREMER, Patrick SUESS, Christian SCHOENEFELD, Jochen SIEBERLING, Renate SEEGER, Anna Lisa HAWLITSCHEK
  • Publication number: 20190239544
    Abstract: The present invention relates to the use of one or more pearlescent pigments based on flake-form substrates for coloring wafers, edible paper and similar baked goods.
    Type: Application
    Filed: February 7, 2018
    Publication date: August 8, 2019
    Applicant: MERCK PATENT GMBH
    Inventor: Ralf SCHWEINFURTH
  • Publication number: 20190241811
    Abstract: The present invention relates to liquid crystalline media comprising one or more naphthothiadiazol derivatives of formula I, in which R11, R12, A11, A12, A21, A22, Z11, Z12, Z21, Z22, W, X11, X12, L, r, s and t have the meanings indicated in claim 1, to the use of such liquid crystal media for optical, electro-optical and electronic purposes, in particular in devices for regulating the passage of energy from an outside space into an inside space, for example in windows.
    Type: Application
    Filed: June 26, 2017
    Publication date: August 8, 2019
    Applicant: Merck Patent GmbH
    Inventors: Peer KIRSCH, Rene LUTZ, Michael JUNGE, Ursula PATWAL
  • Publication number: 20190241809
    Abstract: Liquid-crystalline media (LC media) comprising self-aligning mesogens (self-alignment additives) which effect homeotropic (vertical) alignment of the LC media at a surface or the cell walls of a liquid-crystal display (LC display). The self-alignment additives contain five-ring systems. LC displays having homeotropic alignment of the liquid-crystalline medium (LC medium) without conventional alignment layers are provided.
    Type: Application
    Filed: February 5, 2019
    Publication date: August 8, 2019
    Applicant: Merck Patent GmbH
    Inventors: Melanie KLASEN-MEMMER, Edward PLUMMER, Rocco FORTTE, Helmut HAENSEL, Timo UEBEL, Tamara LEHMANN
  • Patent number: 10369217
    Abstract: The present invention is directed to nanoparticles comprising chitosan and an antigen, whereby the chitosan has a degree of deacetylation of about 90% and a molecular weight from 5 kDa to 80 kDa, to microparticles containing such nanoparticles as well as to a process for preparation of such particles. The particles are usable for vaccination.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: August 6, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Andrea Hanefeld, Markus Weigandt, Michael Wolf, Percy Knolle, Matthias Schroeder, Regina Scherliess, Peter Walden, Andrea Diedrich, Hartwig Steckel, Renato Brito Baleeiro
  • Patent number: 10374162
    Abstract: The invention relates to fullerene derivatives of formula I, to mixtures and formulations containing them, to the use of the fullerene derivatives, mixtures and formulations as organic semiconductors in, or for the preparation of electronic devices, especially organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to electronic devices comprising, or being prepared from, these fullerene derivatives, mixtures or formulations.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: August 6, 2019
    Assignees: Merck Patent GmbH, Nano-C, Inc.
    Inventors: Nicolas Blouin, Stephane Berny, Edward A. Jackson, Henning Richter
  • Patent number: 10374170
    Abstract: The invention relates to materials, to electroluminescence devices comprising said materials and to the use thereof.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: August 6, 2019
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Arne Buesing, Philipp Stoessel, Anja Gerhard, Christof Pflumm, Thomas Eberle, Anja Jatsch, Jonas Valentin Kroeber, Lars Dobelmann-Mara
  • Patent number: 10374167
    Abstract: The present invention relates to novel compounds according to formula (I) having a six-membered ring structure substituted with electron donor, electron acceptor and sterically demanding groups. Said compound is suited for use in organic electronic devices, particularly in organic electroluminescent devices (OLEDs). Formula (I) wherein Q1 and Q2 are independently of each other selected from the group consisting of N, CRA, CRD, and CRS; Z1 and Z2 are independently of each other selected from the group consisting of N, CRA and CRD; RA is a group with ?M-effect; RD is a group with +M-effect; and RS is a sterically demanding group, with the provision that the compound of general formula (I) comprises at least one group CRA and at least one group CRD.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: August 6, 2019
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Amir Hossain Parham, Christof Pflumm, Anja Jatsch
  • Patent number: 10369831
    Abstract: The present invention relates to a printed image comprising flake-form effect pigments which has striking matt/gloss effects, to a process for the production of a printed image of this type, and to the use thereof, in particular in security printing.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: August 6, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Sylke Klein, Heidemarie Montag